Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

Acanthosis nigricans in teenage girls with PCOS is a sign of obesity, not insulin resistance or glucose intolerance.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Finasteride and flutamide can effectively treat hirsutism, with abdominal hairs showing the most sensitivity to the treatment.

Both finasteride and metformin effectively treat PCOS by reducing hormone levels and insulin resistance.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Hormonal therapies are safe and effective for treating adult women's acne.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.